HTB

Conference reports

Third International Workshop on Salvage Therapy for HIV Infection, April 12-14, 2000, Chicago, USA

Clinical studies of indinavir/ritonavir as salvage therapy

Indinavir plus ritonavir: might exposure to higher levels of indinavir overcome protease resistant HIV and prove useful to ‘rescue’ previously failed protease inhibitor based combinations?

First International Workshop in Clinical Pharmacology in HIV Therapy, 30-31 March 2000, Noordwijk, Netherlands

TDM: standardisation and quality control

TDM in clinical practice

ATHENA – Early results from first randomised study of clinical benefits of TDM

TDM for individualising dosing – practicality and efficacy for PIs and RTIs

TDM and adherence

Drug interactions: amprenavir, saquinavir, ABT-378/r (lopinavir/r), indinavir, efavirenz, ritonavir

L-Acetyl Carnitine (LAC) improves symptoms of peripheral neuropathy (PN): evidence for increases in cutaneous innervation

7th Conference on Retroviruses and Opportunistic Infections (ROI), January 30-February 2 2000, San Francisco

Paediatrics: children are not small (or miniature) adults

HIV-positive women, pregnancy and newborns

Flu-like symptoms of severe acute HIV infection develop after suspension of HAART

Non-clade B virus: epidemiology, testing strategies and resistance

Post navigation